Total testosterone, sex hormone‐binding globulin, and free testosterone concentrations and risk of primary liver cancer: A prospective analysis of 200,000 men and 180,000 postmenopausal women
Open Access
- 5 November 2024
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 156 (8) , 1518-1528
Abstract
In most countries, males have ~2–3 times higher incidence of primary liver cancer than females. Sex hormones have been hypothesized to contribute to these differences, but the evidence remains unclear. Using data from the UK Biobank, which included ~200,000 males and ~180,000 postmenopausal females who provided blood samples at recruitment, we estimated hazard ratios (HR2) and 95% confidence intervals (CI) for a doubling in hormone concentration from multivariable adjusted Cox regression for circulating total testosterone, sex‐hormone binding globulin (SHBG), and free testosterone concentrations and risk of primary liver cancer. After a median of 11.8 years of follow‐up, 531 cases of primary liver cancer were observed, of which 366 occurred in males and 165 occurred in females. Total testosterone and SHBG were shown to be positively associated with liver cancer risk in both males and females (Total testosterone HR2: 3.42, 95% CI:2.42–4.84 and 1.29, 0.97–1.72, respectively; SHBG HR2: 5.44, 4.42–6.68 and 1.52, 1.09–2.12, respectively). However, free testosterone was inversely associated with primary liver cancer in males (HR2: 0.42, 0.32–0.55) and no association was observed in females. When analyses compared two main liver cancer subtypes, hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC), there was evidence of heterogeneity; associations for total testosterone and SHBG concentrations were only positively associated with HCC in both males (HR2: 3.56, 2.65–4.79 and 7.72, 6.12–9.73, respectively) and females (HR2: 1.65, 1.20–2.27 and 6.74, 3.93–11.5, respectively) but not with ICC. Further research understanding the mechanisms of how sex‐steroids may influence liver cancer risk is needed.Keywords
Funding Information
- Canadian Institutes of Health Research (187861)
This publication has 50 references indexed in Scilit:
- Testosterone, β-estradiol, and hepatocellular carcinoma: stimulation or inhibition? A comparative effect analysis on cell cycle, apoptosis, and Wnt signaling of HepG2 cellsNaunyn-Schmiedeberg's Archives of Pharmacology, 2024
- Sex disparities in the incidence of 21 cancer types: Quantification of the contribution of risk factorsCancer, 2022
- Prospective analyses of testosterone and sex hormone‐binding globulin with the risk of 19 types of cancer in men and postmenopausal women in UK BiobankInternational Journal of Cancer, 2021
- Epidemiology of Hepatocellular CarcinomaHepatology, 2020
- Associations Between Prediagnostic Concentrations of Circulating Sex Steroid Hormones and Liver Cancer Among Postmenopausal WomenHepatology, 2020
- Significance and mechanism of androgen receptor overexpression and androgen receptor/mechanistic target of rapamycin cross‐talk in hepatocellular carcinomaHepatology, 2017
- Prediagnostic plasma testosterone, sex hormone‐binding globulin, IGF‐I and hepatocellular carcinoma: Etiological factors or risk markers?International Journal of Cancer, 2013
- Splines, knots, and penaltiesWIREs Computational Statistics, 2010
- A cohort study of serum testosterone and hepatocellular carcinoma in Shanghai, ChinaInternational Journal of Cancer, 1995
- Mechanism of feminization in male patients with non-alcoholic liver cirrhosis: Role of sex hormone-binding globulinGastroenterologia Japonica, 1991